EMA Authorised: Aubagio (teriflunomide) — Sanofi Winthrop Industrie

View source ↗

Summary

The EMA authorised Aubagio (teriflunomide) for multiple sclerosis, with Sanofi Winthrop Industrie listed as the marketing authorisation holder; decision date 06…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• AUBAGIO (TERIFLUNOMIDE)

Snippet

Status: Authorised. Therapeutic area: Multiple Sclerosis. MAH: Sanofi Winthrop Industrie. Decision date: 06/11/2025